Article
APOL1 variant alleles associate with reduced risk for opportunistic infections in HIV infection.
Communications biology - 5 Mar 2021
An Ping, Sezgin Efe, Kirk Gregory D, Duggal Priya, Binns-Roemer Elizabeth, Nelson George, Limou Sophie, Van Natta Mark L, Jabs Douglas A, Estrella Michelle, Kopp Jeffrey B, Winkler Cheryl A
Abstract excerpt
Apolipoprotein L1 (APOL1), an innate immune factor against African trypanosoma brucei, inhibits HIV-1 in vitro. The impact of APOL1 G1-G2 variants on HIV-1-associated opportunistic infections (OIs) is unknown. Here, we report findings from a metaanalysis of four HIV/AIDS prospective cohorts (ALIVE, LSOCA, MACS, and WIHS) including 2066 African American participants. Using a global test combining all four cohorts,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
